Institutional Ownership
Immunic Inc
CUSIP 4525EP101COMIMUXQ1 2026
13D / 13G Filings
65
Schedule 13D/13G on record
Beneficial Filers
32
Distinct reporting persons
Largest Stake
11.0%
Max % of class reported
Institutional Holders
72
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
65 filings · latest Mar 4, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 4, 2026 | Deep Track Capital, LP | 13G | 8.7% | 11.45M | SEC |
| 2 | Feb 24, 2026 | Commodore Capital LP | 13G | 11.0% | 13.35M | SEC |
| 3 | Feb 24, 2026 | Trails Edge Capital Partners, LP | 13G | 8.7% | 11.45M | SEC |
| 4 | Feb 20, 2026 | Vivo Opportunity Fund Holdings, L.P. | 13G | 10.0% | 29.13M | SEC |
| 5 | Feb 20, 2026 | Biotechnology Value Fund L P | 13D | 10.0% | — | SEC |
| 6 | Feb 19, 2026 | Soleus Capital Master Fund, L.P. | 13G | 5.5% | 6.79M | SEC |
| 7 | Feb 17, 2026 | Alyeska Investment Group, L.P. | 13G/A | 6.2% | 7.50M | SEC |
| 8 | Feb 17, 2026 | 683 Capital Management, LLC | 13G/A | 5.9% | 7.50M | SEC |
| 9 | Feb 13, 2026 | Nantahala Capital Management, LLC | 13G/A | 8.2% | 10.38M | SEC |
| 10 | Feb 2, 2026 | Aberdeen Group PLC | 13G/A | 6.8% | 8.24M | SEC |
55 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Immunic Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Aberdeen Group PLC | 8.24M | $9.15M |
| 2 | Bvf Inc/Il | 7.65M | $8.49M |
| 3 | Avidity Partners Management LP | 6.70M | $7.44M |
| 4 | Soleus Capital Management, L.P. | 4.50M | $5.00M |
| 5 | Laurion Capital Management LP | 3.88M | $4.31M |
| 6 | Millennium Management LLC | 3.78M | $4.20M |
| 7 | Morgan Stanley | 3.29M | $3.65M |
| 8 | Nantahala Capital Management, LLC | 2.51M | $2.78M |
| 9 | 683 Capital Management, LLC | 2.45M | $2.72M |
| 10 | Propel Bio Management, LLC | 2.34M | $2.62M |